Today: 10 June 2026
Shell Plc share price faces a key week after OPEC+ holds output, earnings due Feb. 5
1 February 2026
1 min read

Shell Plc share price faces a key week after OPEC+ holds output, earnings due Feb. 5

London, Feb 1, 2026, 20:33 GMT — Market closed

Shell shares enter the new week as oil traders digest OPEC+’s move to maintain current output levels through March. Markets reopen Monday, with Shell’s quarterly earnings set to drop later in the week.

The London-listed share finished Friday at 2,794 pence (£27.94), slipping 0.13% that day, per market data. With markets closed until Monday, focus turns to crude oil prices and how the company will interpret its cash flow.

Shell will release its fourth-quarter results and set its next interim dividend on Feb. 5. According to the company’s schedule, ordinary shares go ex-dividend on Feb. 19, while ADSs—depositary receipts representing those shares—follow on Feb. 20. The dividend payment is slated for March 30.

Shell is also leaning on its buyback strategy. The company has a $3.5 billion share repurchase program underway, cutting the share count as it cancels stock. It plans to wrap this up before releasing its Q4 results.

OPEC+ — the cartel including OPEC members plus allies like Russia — kept its output policy steady for March, amid rising US-Iran tensions. Brent crude closed near $70 a barrel on Friday, after hitting a six-month peak of $71.89 the day before. Jorge Leon from Rystad Energy noted, “The lack of forward guidance is significant.” Reuters

Shell revealed in a filing Friday that it repurchased 689,103 shares on the London Stock Exchange and 671,953 on Euronext Amsterdam, all earmarked for cancellation. The trades were handled by Merrill Lynch International, with a volume-weighted average price of £27.8407 in London and €32.1997 in Amsterdam.

Analysts are approaching the report with a narrow range of forecasts. A Vara Research survey, updated Jan. 28, pegged consensus adjusted earnings at $3.509 billion for the quarter and flagged a slight loss anticipated in the Chemicals & Products segment.

Shell has already flagged concerns about this segment. In its Jan. 8 quarterly update, the company noted that Chemicals & Products adjusted earnings were expected to fall below break-even in Q4. The indicated chemicals margin came in at $140 a tonne, with trading and optimisation costs “significantly lower” than in Q3. Shell

The oil backdrop cuts both ways. Should the Iran risk premium ease or demand concerns resurface, crude prices could plunge quickly—and energy stocks tend to tumble right after.

For Shell, along with BP and TotalEnergies, buyback and dividend guidance holds as much weight as headline profits. Quarterly trading results often fluctuate wildly, making them tough for investors to predict.

Investors are eyeing Shell’s Feb. 5 report, eager to hear management’s stance on shareholder payouts and if the uptick in oil prices late last month shifts their outlook.

Stock Market Today

  • Copart (CPRT) Share Price Slump Raises Reassessment Questions Amid Undervaluation
    June 10, 2026, 8:50 AM EDT. Copart's share price has declined 37.7% over the past year, prompting investors to reassess its value. Recent trading closed at $31.31, a 1.5% rise over seven days but down 17.1% year to date. A Discounted Cash Flow (DCF) analysis estimates Copart's intrinsic value at $38.93, suggesting the stock is undervalued by approximately 19.6%. The DCF model, focusing on future free cash flow projections, indicates potential upside if cash flow assumptions hold. Copart trades at a Price-to-Earnings (P/E) ratio of 18.66, reflecting investor expectations on growth and risk. The prolonged multi-year price slump, coupled with evolving market perceptions in vehicle auction and salvage sectors, is driving fresh investor scrutiny on Copart's risk and growth potential.

Latest articles

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Shares Fall Again; Microsoft AI Cloud Agreement Still in Focus

10 June 2026
IREN plunged 8.73% to $54.02 Tuesday and slid another 3.72% premarket as investors weighed Wall Street’s bullish calls on its AI cloud buildout against a tech and crypto selloff; the stock’s fate now hinges on IREN’s ability to deliver Microsoft- and Nvidia-linked AI infrastructure on schedule, with the Microsoft contract at risk if timelines slip.
HSBC share price near a 52-week high: what to watch before London opens
Previous Story

HSBC share price near a 52-week high: what to watch before London opens

Infineon stock price: IFX heads into earnings week after a soft close — what to watch next
Next Story

Infineon stock price: IFX heads into earnings week after a soft close — what to watch next

Go toTop